Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Immunology Right
  3. Olumiant (baricitinib) tablets Right
  4. How is Olumiant® (baricitinib) supplied and how should it be stored?
Search Olumiant (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Baricitinib

Olumiant® (baricitinib) tablets

1mg, 2mg, 4mg
Full Prescribing Information

baricitinib

1mg, 2mg, 4mg

HCP Fact Sheet | Patient & Caregiver Fact Sheet | FDA Authorization Letter

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

How is Olumiant® (baricitinib) supplied and how should it be stored?

Olumiant is supplied as debossed, film-coated, tablets in 1 mg, 2 mg, and 4 mg strengths. Store tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

US_cFAQ_BAR019_HOW_SUPPLIED_STORAGE
US_cFAQ_BAR019_HOW_SUPPLIED_STORAGE
en-US

See important safety information, including boxed warning, in the attached prescribing information.

How Supplied

Olumiant for oral administration is available as debossed, film-coated, tablets. Each tablet contains a recessed area on each face of the table surface.1 See Description of Olumiant (baricitinib) Tablets for description details.

Description of Olumiant (baricitinib) Tablets1

Description

Olumiant 1 mg tablet

Olumiant 2 mg tablet

Olumiant 4 mg tablet

Color

Very light pink

Light pink

Medium pink

Shape

Round

Oblong

Round

Identification on tablet surface sides

"Lilly"
"1"

"Lilly"
"2"

"Lilly"
"4"

Bottle count

30

30

30

NDC

0002-4732-30

0002-4182-30

0002-4479-30

Abbreviations: NDC = National Drug Code.

Storage and Handling

Store tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).1 

Keep out of reach of children.1

Enclosed Prescribing Information

OLUMIANT® (baricitinib) tablets, for oral use, Lilly

Reference

1Olumiant [package insert]. Indianapolis, IN: Eli Lilly and Company; 2022.

Date of Last Review: May 31, 2022

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly